Antengene Corporation Ltd
HKEX:6996
Antengene Corporation Ltd
Inventory
Antengene Corporation Ltd
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Antengene Corporation Ltd
HKEX:6996
|
Inventory
¥13.2m
|
CAGR 3-Years
72%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Inventory
¥653.5m
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Inventory
¥2.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
10%
|
CAGR 10-Years
17%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Inventory
¥5.8B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
0%
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
Inventory
¥4.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
13%
|
CAGR 10-Years
14%
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Inventory
¥162.2m
|
CAGR 3-Years
25%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
Antengene Corporation Ltd
Glance View
Antengene Corp. Ltd. operates as clinical-stage Asia-Pacific biopharmaceutical company. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-11-20. The firm is principally engaged in the discovery, development, manufacturing and commercialization of biotech products. The Company’s products include ATG-010 (selinexor), treating for relapsed/refractory multiple myeloma, relapsed/refractory diffuse large B-cell lymphoma and non-small cell lung cancer and ATG-008 (onatasertib), treating for hepatocellular carcinoma and non-small cell lung cancer. The firm mainly conducts its business in Asia-Pacific.
See Also
What is Antengene Corporation Ltd's Inventory?
Inventory
13.2m
CNY
Based on the financial report for Dec 31, 2024, Antengene Corporation Ltd's Inventory amounts to 13.2m CNY.
What is Antengene Corporation Ltd's Inventory growth rate?
Inventory CAGR 3Y
72%
Over the last year, the Inventory growth was -14%. The average annual Inventory growth rates for Antengene Corporation Ltd have been 72% over the past three years .
